AnaptysBio, Inc. (ANAB)
NASDAQ: ANAB · Real-Time Price · USD
23.39
-0.43 (-1.81%)
At close: Jun 18, 2025, 4:00 PM
23.50
+0.11 (0.47%)
After-hours: Jun 18, 2025, 5:26 PM EDT
AnaptysBio Employees
AnaptysBio had 136 employees as of December 31, 2024. The number of employees increased by 19 or 16.24% compared to the previous year.
Employees
136
Change (1Y)
19
Growth (1Y)
16.24%
Revenue / Employee
$822,588
Profits / Employee
-$1,034,000
Market Cap
687.21M
Employees Chart
Related Stocks
Company Name | Employees |
---|---|
UnitedHealth Group | 400,000 |
Johnson & Johnson | 138,100 |
Abbott Laboratories | 114,000 |
AstraZeneca | 94,300 |
Novo Nordisk | 77,349 |
Novartis AG | 75,883 |
Merck & Co. | 75,000 |
AbbVie | 55,000 |
ANAB News
- 9 days ago - AnaptysBio: Rosnilimab's RA Data Sets The Stage For Blockbuster Potential - Seeking Alpha
- 12 days ago - AnaptysBio: Positive RA Data Bodes Well For Continued Rosnilimab Advancement - Seeking Alpha
- 15 days ago - AnaptysBio's Arthritis Drug Matches Top Therapies In Phase 2 Trial, Analyst Sees Turning Point - Benzinga
- 15 days ago - Anaptys Announces Positive Rosnilimab Data Updated Through Six Months in Robust Phase 2b Trial in RA - GlobeNewsWire
- 22 days ago - Anaptys to Announce Updated Data from Phase 2b Trial of Rosnilimab, a PD-1 Depleter and Agonist, for Rheumatoid Arthritis on June 3, 2025 - GlobeNewsWire
- 6 weeks ago - Anaptys Announces First Quarter 2025 Financial Results and Provides Business Update - GlobeNewsWire
- 3 months ago - Anaptys Announces Stock Repurchase Plan - GlobeNewsWire
- 3 months ago - Anaptys Announces Fourth Quarter and Full Year 2024 Financial Results and Provides Business Update - GlobeNewsWire